SCHOTT Pharma confirms outlook for FY 24 based on Q2 results; FY 25 impacted by slower growth from s pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.
EQS-News: SCHOTT Pharma AG & Co. KGaA / Key word(s): Annual Report/ForecastSCHOTT Pharma delivers on 2023 targets and continues profitable growth trajectory 26.01.2024 / 07:00 CET/CESTThe issuer is solely responsible for the content of this announcement.SCHOTT Pharma delivers on 2023 targets and continues profitable.
Following growth in the past financial year, pharmaceutical supplier Schott Pharma is planning further increases. In the new financial year to the end of September, sales should increase by nine to.